BUZZ-Biomerica rises after securing first major European order for stomach infection test
Reuters03-18
BUZZ-Biomerica rises after securing first major European order for stomach infection test
** Shares of diagnostics maker Biomerica BMRA.O rise 8.2% to $2.25 premarket
** Co says it secured its first commercial European order for its Hp Detect stool test from one of Europe’s largest lab chains
** Test detects H. pylori, a common stomach bacteria that can cause ulcers and stomach cancer and is hard to treat due to antibiotic resistance - BMRA
** Order is for the UK market and follows approval from the UK medicines regulator in February, co says
** Adds the lab chain’s wide reach could help expand sales across Europe and lead to repeat orders as testing becomes routine
** Says H. pylori affects about 45% of people in Europe’s five biggest countries
** BMRA rose ~5% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments